BUILDING A LEADING ONCOLOGY FRANCHISE

DIFFERENTIATED CANDIDATES ADDRESSING CLEAR NEEDS

STRONG FINANCIALS, OPTIMALLY BUILDING VALUE

View our 2018 annual report.

Latest News

MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies
MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights
MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference
MEI Pharma to Release 2018 Fiscal Year End Financial Results and Provide Corporate Update on August 30, 2018